Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Cyproterone MeSH Descriptor Data 2025


MeSH Heading
Cyproterone
Tree Number(s)
D04.210.500.745.432.219
D04.210.500.883.419
Unique ID
D003534
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D003534
Scope Note
An anti-androgen that, in the form of its acetate (CYPROTERONE ACETATE), also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females.
Entry Term(s)
Cyproterone, 1alpha,2 alpha,9 beta,10 alpha-Isomer
Pharm Action
Androgen Antagonists
Registry Numbers
E61Q31EK2F
34554-28-4
Related Numbers
2098-66-0
34554-28-4
CAS Type 1 Name
3'H-Cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione, 6-chloro-1,2-dihydro-17-hydroxy-, (1beta,2beta)-
NLM Classification #
WJ 875
Previous Indexing
Androgens/antagonists & inhibitors (1968-1971)
Public MeSH Note
74
History Note
74(72)
Date Established
1974/01/01
Date of Entry
1999/01/01
Revision Date
2016/05/28
Cyproterone Preferred
Cyproterone, 1alpha,2 alpha,9 beta,10 alpha-Isomer Narrower
page delivered in 0.128s